ZTS (STOCKS)
ZOETIS INC.
$118.595000
+0.735000 (+0.62%)
Prev close: $117.860000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Kristin C. Peck
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $50,691.24M
- Employees
- 13,800
- P/E (TTM)
- 19.57
- P/B (TTM)
- 15.04
- Dividend Yield
- 172.24%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $9.47B |
| Benefits Costs and Expenses | $6.11B |
| Cost Of Revenue | $2.67B |
| Costs And Expenses | $6.11B |
| Gross Profit | $6.80B |
| Nonoperating Income/Loss | $36.00M |
| Operating Expenses | $3.44B |
| Selling, General, and Administrative Expenses | $2.38B |
| Other Operating Expenses | $1.06B |
| Operating Income/Loss | $3.36B |
| Income/Loss From Continuing Operations After Tax | $2.67B |
| Income/Loss From Continuing Operations Before Tax | $3.36B |
| Income Tax Expense/Benefit | $687.00M |
| Income Tax Expense/Benefit, Deferred | -$52.00M |
| Interest Expense, Operating | $222.00M |
| Net Income/Loss | $2.67B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $2.67B |
| Net Income/Loss Available To Common Stockholders, Basic | $2.67B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.03 |
| Diluted Earnings Per Share | $6.02 |
| Basic Average Shares | 443,443,000 |
| Diluted Average Shares | 443,835,000 |
| Common Stock Dividends | $2.03 |
| Assets | $15.47B |
| Current Assets | $6.77B |
| Inventory | $2.43B |
| Other Current Assets | $4.34B |
| Noncurrent Assets | $8.70B |
| Fixed Assets | $3.68B |
| Intangible Assets | $998.00M |
| Other Non-current Assets | $4.02B |
| Liabilities | $12.14B |
| Current Liabilities | $2.24B |
| Accounts Payable | $487.00M |
| Wages | $410.00M |
| Other Current Liabilities | $1.34B |
| Noncurrent Liabilities | $9.90B |
| Equity | $3.33B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.33B |
| Liabilities And Equity | $15.47B |
| Net Cash Flow From Operating Activities | $2.90B |
| Net Cash Flow From Operating Activities, Continuing | $2.90B |
| Net Cash Flow From Investing Activities | -$748.00M |
| Net Cash Flow From Investing Activities, Continuing | -$748.00M |
| Net Cash Flow From Financing Activities | -$1.87B |
| Net Cash Flow From Financing Activities, Continuing | -$1.87B |
| Exchange Gains/Losses | $39.00M |
| Net Cash Flow | $325.00M |
| Net Cash Flow, Continuing | $286.00M |
| Comprehensive Income/Loss | $2.78B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.78B |
| Other Comprehensive Income/Loss | $106.00M |